Skip to main content
reccyneuro
Sign inCreate your profile
Robeauté logo

Robeauté

Paris, France

Robeauté is a medical device company developing a microrobotic platform designed to navigate brain tissue for more precise neurosurgical diagnosis, treatment and monitoring. Founded in Paris in 2017, it is building an integrated infrastructure that combines the Dot microrobot with surgical planning, deployment and tracking systems.

See 8 open rolesrobeaute.com ↗
Open roles
8
Posted last 30 days
2

reccy insights

Recent highlights

In January 2025 Robeauté raised a $28 million Series A led by Plural, Cherry Ventures and Kindred Ventures, with LocalGlobe, Think.Health and APEX Ventures participating, to develop its neurosurgical microrobots for brain biopsy, drug delivery and stimulation.

Written by reccy's AI from company sites, press and funding records · updated Oct 2026

Open roles8

2 roles posted in the last 30 days

  1. 0May
  2. 0Jun
  3. 4Jul
  4. 1Aug
  5. 3Sep
  6. 0Oct

What makes Robeauté distinct

  1. 01Developing a flexible microrobot for curved, three-dimensional navigation through brain tissue, rather than only linear access.
  2. 02One platform is being developed for localized biopsy, targeted drug delivery and brain stimulation.
  3. 03The planned system integrates imaging, procedure planning, navigation, microrobot deployment, retrieval and tracking.
  4. 04The company reports a portfolio of more than 50 patents and input from over 100 neurosurgeons and clinical advisors.

Technology & products

  • Dot microrobot platform for navigation through brain tissue.
  • MOM surgical console for integrated imaging, planning and navigation.
  • CAP launcher for deployment and retrieval, with real-time sub-millimetric tracking.
  • Dot.Biopsy, Dot.Drug and Dot.Electrode procedure-specific applications.
  • Interchangeable procedure payloads and an ultra-thin microwire tether.

About Robeauté

Headquarters
Paris, France